Live
FierceBiotechMedline hit with FDA warning letter over defective heart syringes, safety hazardsLonza NewsLonza Group AG stock: What investors need to know for long-term growth - AD HOC NEWSBioPharma DiveSidewinder secures $137M to advance ‘precision’ ADCsWatersWaters Corporation Receives FDA Clearance for At-Home HPV Self-Collection Kit - Healthcare PackagingAgilentHow New Diagnostic Win and Patent Loss Will Impact Agilent Technologies (A) Investors - simplywall.stEndpoints NewsPhRMA head Steve Ubl to step down at end of yearBioPharma DiveWith 3 quick buyouts, Gilead leans into its latest transformationFierceBiotechArtivion nabs PMA clearance for aortic stent graft system, triggers Endospan buyout optionFierceBiotechWith $2B Novo deal in the books, Vivtex isn't 'limited to being just a drug delivery company': CEOFierceBiotechAstellas unearths Dyno muscle disorder AAV capsid with $15M option agreementFierceBiotechAkari locks arms with WuXi XDC to develop and manufacture novel ADC treatmentBioWorldAppointments and advancements for April 8, 2026
FierceBiotech Apr 8, 2026

Medline hit with FDA warning letter over defective heart syringes, safety hazards

Medline hit with FDA warning letter over defective heart syringes, safety hazards

Original
Body unavailable. Use the original source.

Directory

59 All